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Fleas are the most common ectoparasites in cats and are 
present in many areas of the world, with Ctenocephalides 
felis Bouché, 1835, being the most frequent flea species on 
cats followed by Ctenocephalides canis (Cadiergues et al. 
2000, Beck et al. 2006, Bond et al. 2007, Gracia et al. 2013).
Cat fleas play an important role as vectors. C. felis is the 
major vector of Bartonella spp., including Bartonella hense-
lae, the agent of cat-scratch disease (CSD) (Chomel et al. 
2006) and acts both as a reservoir host and as a vector for 
Rickettsia felis, the major agent of flea-borne spotted fever 
which is an emerging clinical disease of humans worldwide 
(Pérez-Osorio et al. 2008). The natural route of transmis-
sion of feline haemoplasma infection (Mycoplasma hae-
mofelis) has not been confirmed, but fleas are implicated 
(Tasker 2010). Additionally, cat fleas are the intermediate 
host of Dipylidium caninum. Simple pruritus or Flea aller-
gic dermatitis (FAD) is a very important consequence of 
flea infestation. Signs of this reaction include pruritus, ery-
thema, papules, pustules and crusts (scabs). Also if severe, 
hair loss and anemia may occur. Therefore, effective control 
measures against these parasites are important in prevent-
ing feline and human diseases.
Fipronil and (S)-methoprene have different modes of 
action against insects. Fipronil is a broad spectrum phenyl-
pyrazole with activity against both adult insects and arach-
nids; moreover, it exhibits a high selectivity to insects over 
mammals (Narahashi et al. 2007, Narahashi et al. 2010). 
(S)-methoprene is an insect growth regulator (IGR) causing 
impairment of development and death of insect larval stag-
es. (S)-methoprene is present in the skin lipids and pen-
etrates into flea eggs before they fall off the animals, pro-
viding high and persistent activity against immature stages 
of the cat flea by interfering with the “in situ” development 
of eggs and subsequent inhibition of adult flea emergence 
(Young et al. 2004). Fipronil and (S)-methoprene have been 
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used in combination for the treatment and control of fleas, 
for several years (Dryden et al. 2007, Schnieder et al. 2008, 
Beugnet & Franc 2010).
One potential reason for failure of a flea control pro-
gram is resistance of the insects to the chemicals used. Al-
though resistance to old insecticides including cyclodienes, 
carbamates, organophosphates, and pyrethroids has been 
demonstrated in fleas, (Bossard et al. 2002) resistance 
against modern adulticides in field strains has not. Because 
resistance selection is certainly possible in fleas, it is cru-
cial that we attempt to know the efficacy of the current 
therapeutic agents.
The present work was conducted in order to evalu-
ate the efficacy of a fipronil/(S)-methoprene formulation 
(Frontline Combo® Spot-on, Merial, France) against fleas 
on cats naturally infested. In addition, observations also 
were made on the beneficial effect of treatment on cats 
showing clinical signs of flea infestation, including animals 
with signs of flea allergy dermatitis (FAD).
MATERIALS AND METHODS
Area of study and sample collection. The survey was car-
ried out on a population of 89 cats distributed amongst 24 vet-
erinary practices in 9 regions of Spain (Fig.1). The veterinary 
practices collaborated voluntarily in the survey and only cats 
parasitized by at least one flea at day 0 and untreated for, at least 
two months prior to entry into the study were used. The number 
of cats ranged from 1 to 8 per practice, enrolled by means of a 
random selection among cat owners. The study took place from 
April 2010 to August 2011.
After the informed owner consent had been obtained, animals 
were recruited in the study. Data recorded from each cat include 
age, sex, breed and hair type.
Parasitological and clinical evaluations. Day 0 was defined 
individually as the day the animal was found suitable for recruit-
ment in the study. On day 0, the appropriate parasitological and 
clinical examinations were carried out.
The examining veterinarian performed a flea count accord-
ing to a defined procedure (Marchiondo et al. 2007). The cat was 
combed with a fine-toothed comb over the entire body for 7 min-
utes including dorsal midline (2 min), tail head (2 min), left lateral 
(1 min), right lateral (1 min) and inguinal (1 min). In case of col-
lecting at least one flea, the combing was continued for an extra 
minute over each section. After obtaining the agreement from the 
owner, fleas were put back on the cat in order to mimic as much 
as possible the natural parasitation status of the animal, and the 
real situation of a treated infestation. The same protocol was per-
formed on days 30, 60 and 90. A small sample of fleas obtained on 
day 0, were stored at -20oC and transferred to the Department of 
Animal Pathology (Zaragoza University, Spain) for identification 
purposes (Beaucournu & Launay 1990).
A clinical examination was performed on each cat and der-
matological lesions and abrasions related to the presence of fleas 
(typical FAD sores, scratching and flea bites) as well as flea faeces 
were also recorded. Flea allergy dermatitis was diagnosed on the 
basis of clinical signs and the animal’s history.
Treatment. When the parasitological and clinical evaluations 
were completed, cats were treated. Each cat was treated with 
Frontline Combo® by the veterinarian, following the product la-
beling. Treatments were performed on days 0, 30 and 60.
Additional information. A questionnaire was used to collect 
other data regarding the cats:
Location of the household: considered urban when located 
in a town or in the center of a village, or surrounded entirely by 
urbanized area; considered rural/suburban when located in the 
countryside or in partially urbanized areas.
Outside activity: cats were classified according to their activi-
ty as either partially or totally outdoors (access to a garden, street 
or other outside environments) or entirely indoors.
Multi-pet households: whether residence was shared with 
other pets.
Contact with other pets: whether cats were in contact with 
other pets in the neighborhood.
Period of treatment during the year: whether the cat was tre-
ated for the first time in the warm period (May-October) or in the 
cold period (November-April).
Information related to previous treatments was also recor-
ded: product and frequency of use.
The cats underwent parasitological and clinical assessments 
on days 0, 30, 60 and 90. Even though 89 cats started the study, 
only 75 cats could be followed for the whole period of study.
Statistical analysis. As the sample size decreased from day 
0 to day 90, two separate analyses were performed. In first, data 
obtained on Day 0 were used to explore the relationships between 
flea infestation and host, habitat and management factors record-
ed at the beginning of the survey (Day 0). In order to achieve this, 
a General Linear Model was set up, in which the log-transforma-
tion (Ln (x+1)) of flea abundance in each cat on Day 0 was used 
as dependent variable whereas next variables collected in the 
questionnaire were used as predictor variables: age (in months), 
sex, hair type, location of the household, outside activity, multi-
pet households, contact with other pets, period of treatment in 
the year and time elapsed from last treatment (in months). Cat-
egorical predictor variables were coded as dummy variables. No 
interactions among predictors were included in the initial model. 
A backward selection procedure was used to obtain the final fitted 
model.
Secondly, data obtained from cats that remained enlisted in 
the survey until Day 90 were used to test the efficacy of treat-
ment over time (from day 0 to day 90) and the possible effects 
of host, habitat and management factors. In this case, a General 
Linear Model (Mardia et al. 1979) with repeated measures was 
fitted to data. Flea abundance on days 0, 30, 60 and 90 was used 
as a log-transformed (Ln (x+1)) dependent variable, whereas the 
same predictor variables as in the former analysis were included 
in the initial model. To explore the effects of predictor variables 
on treatment efficacy, second grade interactions among them and 
Fig.1. Map of Spain showing the location of regions where the cats 
were sampled.
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time were included in the initial model. A backward selection 
procedure was used to refine the final one. Post-hoc comparisons 
of log-transformed flea abundance over time were performed by 
Bonferroni test (Cabin & Mitchell 2000).
Efficacy, as percentage reduction in mean flea infestation bur-
den, was assessed over time by comparing mean infestation bur-
dens on day 30, 60 and 90 with mean flea burden registered at 
day 0. The percentage reduction was 100 (1-Xt/Xc) where Xc was 
the arithmetic mean flea burden at day 0 and Xt was the arithme-
tic mean infestation burden on days 30, 60 or 90. Following the 
World Association for the Advancement of Veterinary Parasitolo-
gy (W.A.A.V.P.), the arithmetic mean was preferable to the geomet-
ric mean as it is easier to calculate, it provides a better estimate 
of count outputs and it is a more conservative measure of efficacy 
(Coles et al. 1992).
One tail Chi-square test was used to perform pair comparisons 
of the number of cats with fleas, dermatological lesions, lesions 
related to the presence of fleas (typical FAD lesions, scratching 
and flea bites) and flea faeces among the four sampling periods, 
i.e. days 0, 30, 60 and 90.
RESULTS
Among the 89 cats there were 47 males and 42 females. The 
age distribution is shown in Figure 2. Most cats were Euro-
pean (57 cats), followed by mixed breeds (15), Siamese (9) 
and Persian (8). 71 cats had short hair, 10 medium and 8 
long hairs. Sixty-three cats (70.8%) were surveyed in the 
warm period (May-October) and twenty six (29.2%) in the 
cold period (November-April). Information about aspects 
related to previous treatments (product and frequency of 
use) showed that the owners of 43 cats out of 89 cats stud-
ied, (48.3%) remembered the trademark name of the prod-
uct used to control fleas, while for 46 cats (51.7%) the own-
er was unaware of this information. The active ingredients 
used were mainly fipronil (83.7%, of which 11% combined 
with (S)-methoprene, followed by selamectin (11.6%), and 
imidacloprid (2.3%). Among 41 owners who gave informa-
tion about frequency of treatments against fleas, 46.3% 
treated every 1-3 months throughout the whole year, 7.3% 
treated every 3-6 months throughout the whole year, 19.5 
% treated only during summer time and 26.8% treated 
when the owner considered it appropriate.
A total of 463 fleas were collected, representing two 
species: C. felis and Echidnophaga gallinacea, C. felis was 
the most abundant (458 fleas, 98.9% of the total), while E. 
gallinacea was only recorded from one cat (5 fleas, 1.1% of 
the total) located in Fuerteventura, Canary Islands.
On day 0, a total of 89 cats were enrolled. The minimum 
infestation (1-4 fleas) was found in 20 cats, while most cats 
(52 animals) were infested with 5 to 10 fleas, and 17 ani-
mals were infested with more than 10 fleas (maximum of 
50 fleas in a cat).
Flea abundance at Day 0 (Table 1) was associated with 
hair type, location of the household and time elapsed from 
the last treatment (R2=0.45; F=13.64; P<0.001).  Flea bur-
den was higher in cats with long hair (P<0.001) compared 
with cats with medium or short hair. Flea burden was low-
er in cats living in urban areas (P=0.022) in comparison to 
cats living in rural areas. In addition, a positive relationship 
was found between flea abundance and time elapsed from 
the last treatment used against fleas (P=0.007). No statis-
tically significant (P>0.05) association was found with the 
other factors studied.
Efficacy of treatment
From the 75 animals that were surveyed during the 90 
days, the percentage of flea free cats increased from 0% on 
day 0 to 76% on day 90 (Chi square =237.5; P<0.001). The 
percentage reduction of mean flea burden was 72.6% on 
day 30, 88.4% on day 60 and 93.9% on day 90 when com-
pared to the mean flea burden registered at day 0 (Table 
2). The statistical analysis confirmed that flea abundance 
decreased significantly over time (F=114.38; P<0.001) and 
that decrease was statistically significant (Bonferroni test: 
P<0.01) among all sampling periods, excepting between 
days 60 and 90, when no statistical difference was detected 
(P=0.368).
The monthly treatments were effective to reduce clini-
cal signs related to presence of fleas; dermatological le-
sions (including typical FAD lesions, scratching, and flea 
bites) and presence of flea faeces decreased throughout the 
study. On day 0, before treatment was applied, of 75 cats 
that remained enlisted in the survey until day 90, 20 ani-
Fig.2. Age distribution of the treated cats.
Table 1. Number of cats (N), arithmetic mean of fleas ± SD 
and ranges based on hair type, location of household and 
time elapsed since last treatment
   N Arithmetic Mean SD range
 Hair type Short hair 80 7.79 8.07 1-50
  Long hair 8 20.87 15.72 5-50
 Household Rural/suburban 47 9.47 9.18 1-50
  Urban 42 8.31 10.17 1-50
 Elapsed time since 2-4 months 24 5.42 3.52 1-13
 the last treatment 5-8 months 12 8.08 5.76 3-20
  ≥9 months 39 10.15 9.63 1-50
Table 2. Prevalence of infestation, arithmetic mean ±SD, min-
max of fleas, efficacy (%) and 95% CI from day 0 to day 90
  Prevalence Mean ± SD Min-max Efficacy  IC 95% 
  of infestation   (%) Efficacy
 Day 0 100% (75/75) 8.31±7.8 1 - 50
 Day 30 50.7% (38/75) 2.28±3.56 1 - 14 72.6 57.3 - 82.4
 Day 60 34.7% (26/75) 0.96±1.74 1 - 8 88.4 81.0 - 93.0
 Day 90 24% (18/75) 0.51±1.26 1 - 8 93.9 88.4 - 96.8
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mals had dermatological lesions and flea allergy dermatitis 
was diagnosed clinically in 12 cats, but these prevalences 
were reduced to 5 and 3 cats respectively on day 90. Pair 
comparisons among sampling periods were all statistically 
significant (P < 0.05), excepting reduction of dermatologi-
cal lesions between days 60 to 90 (Chi square = 0.86; P = 
0.354) and reduction of FAD lesions between days 0 to 30 
(Chi square = 1.14; P = 0.286) and between days 60 to 90 
(Chi square = 0.35; P = 0.555). Similarly, the numbers of 
cats with bites or scratching were also reduced from 14 to 
2 and from 35 to 5 respectively. All pair comparisons be-
ing also significant (P<0.05) excepting for cats with bites 
between days 0 to 30 (Chi square =1.85; P=0,174) and 
scratching prevalence between days 60 to 90 (Chi square 
=3.43; P=0.064). Finally, the number of cats with flea feces 
was reduced from 70, on day 0, to 14 on day 90. In this case, 
all pair comparisons were statistically significant too, ex-
cepting between days 30 to 60 (Chi square =2.2; P=0.138).
DISCUSSION
Ctenocephalides felis is the predominant species on cats, as 
reported in other studies carried out in different countries 
(Cadiergues et al. 2000, Beck et al. 2006, Bond et al. 2007) 
including Spain (Gracia et al. 2013). The sticktight flea, 
Echidnophaga gallinacea, is a species frequently found in 
birds but only occasionally in dogs and cats (Beaucournu & 
Launay 1990). Even though this species was not found in a 
previous study carried out in Spain (Gracia et al. 2013) we 
found it, in very low number, in a warm area (The Canary 
Islands).
Flea abundance at Day 0 was associated with hair type, 
location of the household and time elapsed since the last 
treatment. A higher infestation in cats with long hair could 
be explained by the fact that long hair avoids flea capture 
during host grooming. Fleas were less abundant on cats 
living in an urban zone compared to those living in a ru-
ral/suburban zone which is in agreement with Farkas 
et al. (2009). Cats in rural areas live under epidemiolog-
ical conditions favoring heavy flea infestation (Kaal et al. 
2006). The abundance of flea species in cats was mainly 
associated with host habitat and environmental factors 
rather than host-dependent factors (Gracia et al. 2013) and 
studies have showed that the main factor affecting this is 
the life style (indoor/outdoor) and contact with other in-
dividuals (Chin et al. 2005, Dryden et al. 2011b), but our 
analysis, despite specifically studying this circumstance, 
could not back up it. Another factor that affected the flea 
rate was the time elapsed from the last insecticidal treat-
ment. Only cats untreated for, at least, two months before 
the start of the study were included. It is probable that the 
lower abundance of fleas was due to the consequences on 
the environmental flea contamination achieved by the pre-
vious treatments (Dryden et al. 2011a).
The results of this work show that Frontline Combo® 
gives an appropriate control of fleas. Treatment controls 
the natural flea infestations significantly over the duration 
of the trial. Following three monthly application, cat flea 
burdens were reduced by 93.9%. The treatment was effec-
tive in all cats irrespective of their mode of life.
At the end of the study some cats still hosted some fleas, 
even though the parasitic burden was remarkably lower in 
these animals, since only one animal hosted more than 5 
fleas on day 90 while 79 raised that burden on day 0. Our hy-
pothesis is that prior to cat treatment, massive numbers of 
flea eggs were laid in the indoor and outdoor environments 
and therefore the flea biomass (especially pupae) was able 
to continue to allow flea emergence during several weeks 
or months (Bitam et al. 2010). Efficacy improved over time 
as treatments reduced the environmental reservoir. In this 
respect we must point out that not environmental control 
or treatment of in-contact cats in multicat households was 
recommended. In addition, due to the ambulant habits of 
some cats, they might be able to contact sporadically with 
new infection sources far from home. In the current work, 
there were no untreated control groups which would have 
had a high suitability to get to know the natural evolution of 
flea populations. Unfortunately, as the study involved scat-
tered populations of cats over periods that differed among 
them in location and availability of animals, this study de-
sign using control groups was unavailable.
In order to mimic as much as possible the natural par-
asitation status of the animal and the real situation of a 
treated infestation, the fleas were put back on the cat. Al-
though the decision to removal and replace the fleas on the 
animal could be seen as an intervention that had a negative 
impact on the animal welfare and/or natural parasitation 
(damaged of fleas), we want to point out that what is pre-
tended was only quantify the levels of parasitation in the 
sampling dates, this is not performed any experimental in-
fection; and all surveys were carried out with extreme care 
to avoid damaging insects.
Only a Frontline Combo® treatment approximately 
halves the number of cats with dermatological lesions 
and abrasions related to the presence of fleas (typical FAD 
sores, scratching and flea bites) as well as the number of 
cats with flea faeces. Obsessive scratching is the clearest 
indication that a cat is infested with fleas. In our work, we 
can see that already in the first sampling this symptom had 
decreased statistically. In addition, a significant proportion 
of cats reduced all the symptoms related to the presence of 
fleas already from the second sampling. These data shows 
that the treatment with Frontline Combo® was associated 
with a decrease of the clinical signs related to presence of 
fleas.
Although direct comparison with other studies is dif-
ficult, our results are similar to those obtained by other 
authors (Schnieder et al. 2008, Beugnet & Franc 2010, 
Dryden et al. 2011-a) indicating a good level of efficacy for 
fipronil 13 years after its commercial launch in veterinary 
medicine. This study found no evidence of flea resistance to 
Fipronil/(S)-methoprene
CONCLUSIONS
A high level of flea control and a remission of the clini-
cal signs related to presence of fleas were observed on cats 
following 3 monthly application of Frontline Combo®.
Pet owners should be warned that it is not unusual to 
detect some fleas on treated pets for 2-3 months after tre-
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atment. This appears to be particularly true in geographic 
areas with naturally high levels of flea infestations, like 
Spain.
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